Christine PooleApplied MaterialsAMATSELL ON STRENGTHJan 22, 2024

Is up 179% this year. They can't produce enough semis equipment (so are their peers).

This one got away from him. Is up 49% in the past 3 months in a parabolic chart. Take some profits.

Buys back a lot of shares, reducing share count by 31% since end-2015. Is up 52% this year, and 1,274% over 10 years.

Mainly hardware. Competitors are LRCX and KLAC. Manufactures and sells the presses that INTC, Samsung, and TSM will buy to make chips. Also has a software side. Runway of only $270 for 12-month price target. Buy here around $239, add ~$225, and again ~$205. Yield is 0.77%.

It is well balanced between different sectors and good for the long term. His preference is KLA Tencore (KLAC) which is dominant in the space. It is up 29% over the year so you could step in now.

Likes this space, but big names like this and LAM are part of the ETFs, so automatically rise whether that stock should be bought or not. Can be volatile, like last April. Prefers buying on weakness, holding a few years, then selling.

Had a decent quarter, but terrible guidance, 10% below the street in a sector that should be humming (semis equipment). AMAT has responded negatively for the last 6 quarters. Is not performing. He sold.

Peers Lam Research and KLA Corp are performing well, but AMAT is an anomaly, not executing.

Is breaking out and their runway is long, given the AI boom.

It ranks #3 in its sector. They have a lot of exposure to China, which worries many.

It reports Thursday. Watch for the decline on revenues from China YOY. When LAM Research reported, AMAT rose. Options imply a 6% move.

Watch for the decline on revenues from China YOY, but the worse has been priced in already.

Potential topping pattern. Could be the top of the recent strength. Would not recommend buying at this time. Wait for trend to reverse upwards. 

Still a decent runway ahead. 12-month price target of $258. Has built a moat around the wafer and fabrication side, over 50% market share. Buy it here around $198, another 1/3 in low $180s, and final 1/3 in low $170s.

Just reported, but shares dipped 2%. Reported guidance in-line. Maybe the market is worried over their sales in China, but nothing has changed overnight. It's case of shares being up nicely and are guiding conservatively. This is up 28% this year, so he's fine with it. Has $2 billion free cash flow last quarter reported and carries no net debt.